Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells

Transforming growth factor (TGF)-beta 1 has a biphasic effect on rat intestinal epithelial (RIE) cells. By itself, TGF-beta 1 functions as a tumor suppressor by inhibiting the growth, migration and invasion of RIE cells. We show in this study that in conjunction with epidermal-growth factor (EGF), TGF-beta 1 helped to augment migration, invasion and anchorage-independent growth (AIG) compared to that by EGF alone. EGF plus TGF-beta 1 induced a dramatic morphological change characteristic of epithelial-mesenchymal transition (EMT). The mechanism for this enhanced effect of TGF-beta 1 and EGF on oncogenic properties was explored by analysis of EGF- and TGF-beta 1-mediated signaling pathways and complementary DNA arrays. TGF-beta 1 augmented EGF-mediated signaling of mitogen-activated protein kinase (MAPK) and AKT by enhancing and prolonging the activation of the former and prolonging the activation of the latter. Inhibition of MAPK, but not phosphoinositide-3 kinase (PI3K), abolished TGF-beta 1 plus EGF-induced EMT and down-regulation of E-cadherin at mRNA and protein levels. By contrast, cell migration and invasion were sensitive to inhibition of either MAPK or PI3 kinase. TGF-beta 1 plus EGF-induced AIG was significantly more resistant to inhibition of PI3K and MAPK compared to that induced by EGF alone. EGF and TGF-beta 1 synergistically induced the expression of a series of proteases including matrix metalloproteinase (MMP) 1 (collagenase), MMP3, MMP9, MMP10, MMP14 and cathepsin. Among them, the expression of MMP1, MMP3, MMP9 and MMP10 was MAPK dependent. Inhibition of the MMPs or cathepsin significantly blocked EGF plus TGF-beta 1-induced invasion, but had no effect on colony formation. Phospholipase C (PLC) and Cox2 induced by EGF plus TGF-beta 1 also played a significant role in invasion, whereas PLC was also important for colony formation. Our study reveals specific signaling functions and induction of genes differentially required for enhanced effect of EGF- and TGF-beta 1-induced oncogenic properties, and helps to explain the tumor-promoting effect of TGF-beta 1 in human cancer with elevated expression or activation of TGF-beta 1 and receptor protein tyrosine kinases.